Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Physicians Interactive

- PMLiVE

Opdivo approved via UK’s early drug access scheme

Bristol-Myers Squibb’s immunotherapy the first lung cancer drug approved by EAMS

The future of communications is closer than you think

Ashfield Healthcare Communications on how the way physicians learn and keep up-to-date is changing

- PMLiVE

Helping European cardiologists keep up to date

Research reveals significant local differences in how the future of CME is seen

- PMLiVE

A patient’s eye view of the digital doctor

Doctors, patients and using new technologies and social media to help with a long-term condition

- PMLiVE

Novo Nordisk becomes diabetes drug sales leader

Supplants former frontrunner Sanofi - but both firms set for a tough 2015

- PMLiVE

AbbVie remains top of immunology sales

But the threat of biosimilars once again threatens to shake up the leader board

- PMLiVE

Sermo opens its doors in Europe

US online physiciancommunity allows UK doctors to join

Doctors do get mobile, says the BMJ.com

Andthis year the site's morning traffic saw mobile overtake desktop for the first time

- PMLiVE

Relief as study finds no cardiovascular risk with Januvia

FDA continues to investigate safety of numerous diabetes therapies

- PMLiVE

AstraZeneca and PatientsLikeMe team up on real-world data

Two groups hoping to harness the power of the patient forum network

NHS to expand video and email consultation pilots

Move is part of plans to increase patient access to GPs and pharmacists

- PMLiVE

Novartis cancer pill makes it onto UK early access list

Joins Merck’s melanoma drug Keytruda for the MHRA’s accelerated review programme 

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links